1756 Evaluating the Impact of Prophylactic Intrathecal Chemotherapy in Diffuse Large B Cell Lymphoma (DLBCL) Patients with High Central Nervous System International Prognostic Index (CNS-IPI) Scores: A Comprehensive Review and Meta-Analysis

Authors

Kadhim Al-Banaa, Beaumont Health Fellow
Alfarooq Alshaikhli
Shyam Poudel, Beaumont Health Fellow
Shiva Shrotria, Beaumont Health Fellow
Can Wang, Beaumont Health Fellow
Paul Hanona, Beaumont Health Fellow
Swathi Gopishetty, Beaumont Health Fellow
Precious Idogun, Beaumont Health Fellow
Daniel Ezekwudo, Beaumont Health
Ishmael Jaiyesimi, Beaumont Health

Document Type

Conference Proceeding

Publication Date

12-9-2023

Comments

American Society of Hematology Annual Meeting. December 9-12, 2023. San Diego, CA Meeting Abstract: 1756

Recommended Citation

Al-Banaa, Alshaikhki A, Poudel S, Shrotria S, Wang C, Hanona P et al [Gopishetty S, Idogun P, Ezekwudo D, Jaiyesimi IA]. 1756 Evaluating the impact of prophylactic intrathecal chemotherapy in diffuse large b cell lymphoma (dlbcl) patients with high central nervous system international prognostic index (cns-ipi) scores: a comprehensive review and meta-analysis. Presented at American Society of Hematology Annual Meeting; 2023 Dec 9; San Diego, CA.